ALPS Medical Breakthroughs ETF
SBIO
#2375
ETF rank
ยฃ99.91 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ37.70
Share price
0.47%
Change (1 day)
44.77%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of February 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of February 2026: 0.5%